{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:27:25Z","timestamp":1777764445673,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004053","name":"Kawano Masanori Kinen Koeki Zaidan Hojin Kawano Shoni Igaku Shogaku Zaidan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07786"],"award-info":[{"award-number":["18K07786"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26461571"],"award-info":[{"award-number":["26461571"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jaci.2023.05.027","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T02:18:59Z","timestamp":1687400339000},"page":"940-948.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Distinct roles of IL-18 and IL-1\u03b2 in murine model of macrophage activation syndrome"],"prefix":"10.1016","volume":"152","author":[{"given":"Mao","family":"Mizuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Sakumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadafumi","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotoshi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.05.027_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2023.05.027_bib2","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib3","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/25785826.2021.1912893","article-title":"Macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"44","author":"Shimizu","year":"2021","journal-title":"Immunol Med"},{"key":"10.1016\/j.jaci.2023.05.027_bib5","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/rheumatology\/keaa634","article-title":"Clinical\u00a0significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis","volume":"60","author":"Mizuta","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2023.05.027_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.027_bib7","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.05.027_bib8","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2023.05.027_bib9","first-page":"779","article-title":"Circulating levels of interleukin beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis","volume":"13","author":"De Benedetti","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2023.05.027_bib11","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.05.027_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.41103","article-title":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis","volume":"72","author":"Eloseily","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib13","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results om macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.05.027_bib14","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.37958","article-title":"Interferon-\u03b3 mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice","volume":"65","author":"Canna","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2023.05.027_bib15","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/art.33496","article-title":"Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome","volume":"64","author":"Strippoli","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2023.05.027_bib16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/art.38359","article-title":"Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund's complete adjuvant: regulation by interferon-\u03b3","volume":"66","author":"Avau","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib17","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1182\/blood-2010-03-272138","article-title":"Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution","volume":"116","author":"Kovtunovych","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.05.027_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2023.05.027_bib19","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/iai.63.10.3966-3972.1995","article-title":"A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock","volume":"63","author":"Okamura","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2023.05.027_bib20","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFNgamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.05.027_bib21","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.05.027_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-\u03b3 and interferon-\u03b3-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2023.05.027_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon-\u03b3 are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.05.027_bib24","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR-9-induced macrophage activation syndrome in mice","volume":"131","author":"Girard-Guyonvarc\u2019h","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.05.027_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nm987","article-title":"Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration","volume":"10","author":"Heikenwalder","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2023.05.027_bib26","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.20190669","article-title":"Inherited IL-18BP deficiency in human fulminant viral hepatitis","volume":"216","author":"Belkaya","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2023.05.027_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2023.05.027_bib28","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.4049\/jimmunol.1800468","article-title":"Insufficient IL-10 production as a mechanism underlying the pathogenesis of systemic juvenile idiopathic arthritis","volume":"201","author":"Imbrechts","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.05.027_bib29","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1103685","article-title":"IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures","volume":"189","author":"Blom","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.05.027_bib30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib31","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine\u00a0storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.894846","article-title":"Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis","volume":"10","author":"Kostik","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2023.05.027_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep17205","article-title":"Transgenic mouse model for imaging of interleukin-1\u03b2-related inflammation in\u00a0vivo","volume":"5","author":"Iwawaki","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2023.05.027_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpeds.2017.06.005","article-title":"Development and initial validation of the macrophage activation syndrome\/hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome","volume":"189","author":"Minoia","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2023.05.027_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.1989.tb00302.x","article-title":"Pure red cell aplasia in association with virus\u00a0associated haemophagocytic syndrome (VAHS)","volume":"73","author":"Hanada","year":"1989","journal-title":"Br J Haematology"},{"key":"10.1016\/j.jaci.2023.05.027_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.13026","article-title":"Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis","volume":"191","author":"Shimizu","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2023.05.027_bib37","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic -onset juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2023.05.027_bib38","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.05.027_bib39","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/annrheumdis-2015-207818","article-title":"Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan","volume":"75","author":"Yokota","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2023.05.027_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.39407","article-title":"Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab","volume":"68","author":"Grom","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2023.05.027_bib41","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2023.05.027_bib42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2023.05.027_bib43","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.027_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1164\/rccm.201308-1535OC","article-title":"Simultaneous targeting of IL-1 and IL-18 is required for protection against\u00a0inflammatory and septic shock","volume":"189","author":"Vanden Berghe","year":"2014","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923008023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923008023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:04:28Z","timestamp":1777475068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923008023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0091674923008023"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.05.027","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct roles of IL-18 and IL-1\u03b2 in murine model of macrophage activation syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}